Logo image of ECL

ECOLAB INC (ECL) Stock Fundamental Analysis

USA - NYSE:ECL - US2788651006 - Common Stock

258.66 USD
+1.21 (+0.47%)
Last: 11/4/2025, 4:10:02 PM
258.66 USD
0 (0%)
After Hours: 11/4/2025, 4:10:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ECL. ECL was compared to 82 industry peers in the Chemicals industry. ECL scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, ECL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ECL had positive earnings in the past year.
ECL had a positive operating cash flow in the past year.
Of the past 5 years ECL 4 years were profitable.
In the past 5 years ECL always reported a positive cash flow from operatings.
ECL Yearly Net Income VS EBIT VS OCF VS FCFECL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 8.30%, ECL belongs to the top of the industry, outperforming 89.02% of the companies in the same industry.
The Return On Equity of ECL (20.42%) is better than 91.46% of its industry peers.
ECL has a better Return On Invested Capital (11.53%) than 90.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ECL is above the industry average of 6.23%.
The 3 year average ROIC (10.09%) for ECL is below the current ROIC(11.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.3%
ROE 20.42%
ROIC 11.53%
ROA(3y)6.93%
ROA(5y)3.9%
ROE(3y)18.76%
ROE(5y)10.47%
ROIC(3y)10.09%
ROIC(5y)9.38%
ECL Yearly ROA, ROE, ROICECL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ECL's Profit Margin of 12.49% is amongst the best of the industry. ECL outperforms 92.68% of its industry peers.
In the last couple of years the Profit Margin of ECL has grown nicely.
Looking at the Operating Margin, with a value of 17.63%, ECL belongs to the top of the industry, outperforming 85.37% of the companies in the same industry.
ECL's Operating Margin has improved in the last couple of years.
ECL's Gross Margin of 44.36% is amongst the best of the industry. ECL outperforms 90.24% of its industry peers.
In the last couple of years the Gross Margin of ECL has remained more or less at the same level.
Industry RankSector Rank
OM 17.63%
PM (TTM) 12.49%
GM 44.36%
OM growth 3Y5.67%
OM growth 5Y2.23%
PM growth 3Y14.78%
PM growth 5Y5.11%
GM growth 3Y2.05%
GM growth 5Y0.87%
ECL Yearly Profit, Operating, Gross MarginsECL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

6

2. Health

2.1 Basic Checks

ECL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ECL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ECL has been reduced compared to 5 years ago.
The debt/assets ratio for ECL has been reduced compared to a year ago.
ECL Yearly Shares OutstandingECL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ECL Yearly Total Debt VS Total AssetsECL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 5.02 indicates that ECL is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.02, ECL belongs to the best of the industry, outperforming 93.90% of the companies in the same industry.
The Debt to FCF ratio of ECL is 5.19, which is a neutral value as it means it would take ECL, 5.19 years of fcf income to pay off all of its debts.
ECL has a better Debt to FCF ratio (5.19) than 79.27% of its industry peers.
ECL has a Debt/Equity ratio of 0.83. This is a neutral value indicating ECL is somewhat dependend on debt financing.
The Debt to Equity ratio of ECL (0.83) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.19
Altman-Z 5.02
ROIC/WACC1.38
WACC8.37%
ECL Yearly LT Debt VS Equity VS FCFECL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

ECL has a Current Ratio of 1.70. This is a normal value and indicates that ECL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.70, ECL is doing worse than 62.20% of the companies in the same industry.
A Quick Ratio of 1.33 indicates that ECL should not have too much problems paying its short term obligations.
ECL has a Quick ratio (1.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.33
ECL Yearly Current Assets VS Current LiabilitesECL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.59% over the past year.
Measured over the past 5 years, ECL shows a small growth in Earnings Per Share. The EPS has been growing by 2.73% on average per year.
The Revenue has been growing slightly by 1.38% in the past year.
ECL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.10% yearly.
EPS 1Y (TTM)13.59%
EPS 3Y11.38%
EPS 5Y2.73%
EPS Q2Q%13.11%
Revenue 1Y (TTM)1.38%
Revenue growth 3Y7.33%
Revenue growth 5Y1.1%
Sales Q2Q%4.16%

3.2 Future

The Earnings Per Share is expected to grow by 11.90% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.06% on average over the next years.
EPS Next Y14.21%
EPS Next 2Y13.41%
EPS Next 3Y13.49%
EPS Next 5Y11.9%
Revenue Next Year1.97%
Revenue Next 2Y3.69%
Revenue Next 3Y4.1%
Revenue Next 5Y5.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ECL Yearly Revenue VS EstimatesECL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
ECL Yearly EPS VS EstimatesECL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.58, ECL can be considered very expensive at the moment.
63.41% of the companies in the same industry are cheaper than ECL, based on the Price/Earnings ratio.
ECL is valuated rather expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 30.20, which means the current valuation is very expensive for ECL.
64.63% of the companies in the same industry are cheaper than ECL, based on the Price/Forward Earnings ratio.
ECL's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.53.
Industry RankSector Rank
PE 35.58
Fwd PE 30.2
ECL Price Earnings VS Forward Price EarningsECL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

73.17% of the companies in the same industry are cheaper than ECL, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as ECL.
Industry RankSector Rank
P/FCF 47.23
EV/EBITDA 21.06
ECL Per share dataECL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of ECL may justify a higher PE ratio.
ECL's earnings are expected to grow with 13.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.5
PEG (5Y)13.02
EPS Next 2Y13.41%
EPS Next 3Y13.49%

6

5. Dividend

5.1 Amount

ECL has a Yearly Dividend Yield of 1.01%.
ECL's Dividend Yield is comparable with the industry average which is at 3.99.
With a Dividend Yield of 1.01, ECL pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.01%

5.2 History

The dividend of ECL has a limited annual growth rate of 3.93%.
ECL has paid a dividend for at least 10 years, which is a reliable track record.
ECL has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.93%
Div Incr Years34
Div Non Decr Years34
ECL Yearly Dividends per shareECL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

ECL pays out 36.57% of its income as dividend. This is a sustainable payout ratio.
The dividend of ECL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP36.57%
EPS Next 2Y13.41%
EPS Next 3Y13.49%
ECL Yearly Income VS Free CF VS DividendECL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
ECL Dividend Payout.ECL Dividend Payout, showing the Payout Ratio.ECL Dividend Payout.PayoutRetained Earnings

ECOLAB INC

NYSE:ECL (11/4/2025, 4:10:02 PM)

After market: 258.66 0 (0%)

258.66

+1.21 (+0.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-09 2026-02-09/amc
Inst Owners82.4%
Inst Owner Change-1.05%
Ins Owners0.11%
Ins Owner Change0.26%
Market Cap73.36B
Revenue(TTM)15.89B
Net Income(TTM)1.98B
Analysts76.13
Price Target294.75 (13.95%)
Short Float %0.8%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield 1.01%
Yearly Dividend2.34
Dividend Growth(5Y)3.93%
DP36.57%
Div Incr Years34
Div Non Decr Years34
Ex-Date09-16 2025-09-16 (0.65)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.25%
Min EPS beat(2)-1.41%
Max EPS beat(2)-1.09%
EPS beat(4)1
Avg EPS beat(4)-0.7%
Min EPS beat(4)-1.41%
Max EPS beat(4)0.38%
EPS beat(8)1
Avg EPS beat(8)-0.62%
EPS beat(12)5
Avg EPS beat(12)-0.18%
EPS beat(16)5
Avg EPS beat(16)-0.53%
Revenue beat(2)1
Avg Revenue beat(2)-0.33%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.07%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.02%
Max Revenue beat(4)0.07%
Revenue beat(8)1
Avg Revenue beat(8)-0.99%
Revenue beat(12)2
Avg Revenue beat(12)-0.93%
Revenue beat(16)5
Avg Revenue beat(16)-0.53%
PT rev (1m)-1.79%
PT rev (3m)3.2%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)0.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.49%
Valuation
Industry RankSector Rank
PE 35.58
Fwd PE 30.2
P/S 4.62
P/FCF 47.23
P/OCF 27.9
P/B 7.55
P/tB N/A
EV/EBITDA 21.06
EPS(TTM)7.27
EY2.81%
EPS(NY)8.57
Fwd EY3.31%
FCF(TTM)5.48
FCFY2.12%
OCF(TTM)9.27
OCFY3.58%
SpS56.03
BVpS34.27
TBVpS-5.39
PEG (NY)2.5
PEG (5Y)13.02
Graham Number74.87
Profitability
Industry RankSector Rank
ROA 8.3%
ROE 20.42%
ROCE 14.22%
ROIC 11.53%
ROICexc 12.8%
ROICexgc 34.92%
OM 17.63%
PM (TTM) 12.49%
GM 44.36%
FCFM 9.78%
ROA(3y)6.93%
ROA(5y)3.9%
ROE(3y)18.76%
ROE(5y)10.47%
ROIC(3y)10.09%
ROIC(5y)9.38%
ROICexc(3y)10.68%
ROICexc(5y)9.93%
ROICexgc(3y)35.11%
ROICexgc(5y)31.71%
ROCE(3y)12.44%
ROCE(5y)11.62%
ROICexgc growth 3Y15.5%
ROICexgc growth 5Y7.38%
ROICexc growth 3Y16.48%
ROICexc growth 5Y4.33%
OM growth 3Y5.67%
OM growth 5Y2.23%
PM growth 3Y14.78%
PM growth 5Y5.11%
GM growth 3Y2.05%
GM growth 5Y0.87%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.19
Debt/EBITDA 2.14
Cap/Depr 112.57%
Cap/Sales 6.77%
Interest Coverage 250
Cash Conversion 69.97%
Profit Quality 78.27%
Current Ratio 1.7
Quick Ratio 1.33
Altman-Z 5.02
F-Score6
WACC8.37%
ROIC/WACC1.38
Cap/Depr(3y)88.71%
Cap/Depr(5y)80.52%
Cap/Sales(3y)5.47%
Cap/Sales(5y)5.12%
Profit Quality(3y)101.32%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.59%
EPS 3Y11.38%
EPS 5Y2.73%
EPS Q2Q%13.11%
EPS Next Y14.21%
EPS Next 2Y13.41%
EPS Next 3Y13.49%
EPS Next 5Y11.9%
Revenue 1Y (TTM)1.38%
Revenue growth 3Y7.33%
Revenue growth 5Y1.1%
Sales Q2Q%4.16%
Revenue Next Year1.97%
Revenue Next 2Y3.69%
Revenue Next 3Y4.1%
Revenue Next 5Y5.06%
EBIT growth 1Y9.72%
EBIT growth 3Y13.42%
EBIT growth 5Y3.35%
EBIT Next Year47.27%
EBIT Next 3Y20.71%
EBIT Next 5Y16.76%
FCF growth 1Y-8.82%
FCF growth 3Y8.64%
FCF growth 5Y2.35%
OCF growth 1Y8.71%
OCF growth 3Y10.92%
OCF growth 5Y3.06%

ECOLAB INC / ECL FAQ

Can you provide the ChartMill fundamental rating for ECOLAB INC?

ChartMill assigns a fundamental rating of 6 / 10 to ECL.


What is the valuation status for ECL stock?

ChartMill assigns a valuation rating of 2 / 10 to ECOLAB INC (ECL). This can be considered as Overvalued.


How profitable is ECOLAB INC (ECL) stock?

ECOLAB INC (ECL) has a profitability rating of 9 / 10.


What is the financial health of ECOLAB INC (ECL) stock?

The financial health rating of ECOLAB INC (ECL) is 6 / 10.


Can you provide the expected EPS growth for ECL stock?

The Earnings per Share (EPS) of ECOLAB INC (ECL) is expected to grow by 14.21% in the next year.